End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.25 CNY | +0.25% | -4.80% | +8.87% |
Mar. 26 | CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug | MT |
Mar. 22 | CR Double-Crane Pharma's 2023 Profit Jumps 13%, Operating Income Climbs 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.87% | 2.9B | |
+34.14% | 701B | |
+26.24% | 571B | |
+1.09% | 381B | |
+20.76% | 334B | |
+17.10% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-2.94% | 157B |
- Stock
- Equities
- Stock China Resources Double-Crane Pharmaceutical Co.,Ltd. - Shanghai S.E.
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- CR Double-Crane Pharma Wins Deal to Produce Experimental COVID-19 Drug